Skip to main content
Veterinary Medicines

Antiparen N (5,37 g + 1,0 g + 2,0 g + 4,0 g)/100 ml Roztwór do infuzji

Authorised
  • Sodium chloride
  • Magnesium chloride hexahydrate
  • Glucose
  • Calcium chloride hexahydrate

Product identification

Medicine name:
Antiparen N (5,37 g + 1,0 g + 2,0 g + 4,0 g)/100 ml Roztwór do infuzji
Active substance:
  • Sodium chloride
  • Magnesium chloride hexahydrate
  • Glucose
  • Calcium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium chloride
    2.00
    gram(s)
    /
    100.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    1.00
    gram(s)
    /
    100.00
    millilitre(s)
  • Glucose
    4.00
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium chloride hexahydrate
    5.37
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AA20
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1397
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."